CEO Junling Liu shares 111, Inc.’s experience driving change in China’s healthcare and pharmaceutical industry SHANGHAI, Jan. 17, 2020 /PRNewswire/ — Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled “Driving Transformation in China’s Healthcare and Pharmaceutical Industry” at the 38th Annual JP Morgan Healthcare Conference (the “Conference”). The JP Morgan Healthcare Conference, from January 14-18, 2020, in San Francisco, is regarded as one of the world’s most important forums on the global healthcare sector from an investment perspective, sharing insights on emerging industry and investment trends. This year, participants joined from more than 450 public and private companies, with 9,000 attendees including industry leaders, investors and analysts. At the conference, Chairman Liu represented China’s online pharmaceutical and healthcare industry. His presentation focused on the evolving landscape and huge growth potential of China’s online pharmaceutical and healthcare industry, supported b...